ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 107 filers reported holding ADMA BIOLOGICS INC in Q1 2022. The put-call ratio across all filers is 0.75 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $89,500 | -62.1% | 25,000 | -60.9% | 0.04% | -59.2% |
| Q2 2023 | $236,160 | -28.7% | 64,000 | -36.0% | 0.10% | -30.5% |
| Q1 2023 | $331,000 | +12.6% | 100,000 | -17.4% | 0.14% | -15.1% |
| Q3 2022 | $294,000 | +48.5% | 121,000 | +21.0% | 0.17% | +72.9% |
| Q2 2022 | $198,000 | +8.2% | 100,000 | 0.0% | 0.10% | +33.3% |
| Q1 2022 | $183,000 | – | 100,000 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 8,793,321 | $32,447,354 | 11.70% |
| Velan Capital Investment Management LP | 2,726,051 | $10,059,128 | 9.34% |
| Altium Capital Management LP | 2,380,000 | $8,782,200 | 6.65% |
| AWM Investment Company, Inc. | 6,017,572 | $22,204,841 | 3.01% |
| Caligan Partners LP | 847,513 | $3,127,323 | 1.76% |
| Perceptive Advisors | 11,900,255 | $43,911,941 | 1.27% |
| Mesirow Financial Investment Management, Inc. | 51,686 | $190,721 | 0.81% |
| OBERWEIS ASSET MANAGEMENT INC/ | 1,668,700 | $6,157,503 | 0.75% |
| TANG CAPITAL MANAGEMENT LLC | 1,260,000 | $4,649,400 | 0.68% |
| EAM Investors, LLC | 883,842 | $3,261,377 | 0.60% |